Stonebridge Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
4,422
-100
-2% -$27.1K 0.08% 107
2025
Q4
$1.13M Hold
4,522
0.08% 109
2025
Q3
$1.3M Sell
4,522
-25
-0.5% -$6.7K 0.09% 104
2025
Q2
$1.19M Sell
4,547
-110
-2% -$26.8K 0.09% 104
2025
Q1
$1.08M Sell
4,657
-25
-0.5% -$6.07K 0.09% 103
2024
Q4
$1.07M Hold
4,682
0.09% 110
2024
Q3
$1.05M Sell
4,682
-45
-1% -$9.89K 0.09% 113
2024
Q2
$962K Sell
4,727
-3,285
-41% -$668K 0.08% 114
2024
Q1
$1.75M Sell
8,012
-3,172
-28% -$699K 0.16% 103
2023
Q4
$2.54M Sell
11,184
-35
-0.3% -$7.35K 0.26% 79
2023
Q3
$2.26M Sell
11,219
-1,911
-15% -$403K 0.25% 82
2023
Q2
$2.72M Sell
13,130
-952
-7% -$185K 0.29% 76
2023
Q1
$2.78M Sell
14,082
-206
-1% -$42.4K 0.32% 72
2022
Q4
$2.89M Sell
14,288
-327
-2% -$63.9K 0.34% 69
2022
Q3
$2.57M Sell
14,615
-451
-3% -$92.3K 0.33% 74
2022
Q2
$3.03M Sell
15,066
-981
-6% -$209K 0.37% 72
2022
Q1
$3.63M Sell
16,047
-392
-2% -$92.2K 0.39% 66
2021
Q4
$4.44M Buy
16,439
+204
+1% +$50.5K 0.49% 60
2021
Q3
$3.93M Sell
16,235
-20,504
-56% -$5.17M 0.48% 62
2021
Q2
$8.38M Buy
36,739
+18,359
+100% +$4.18M 0.53% 64
2021
Q1
$4.03M Buy
18,380
+160
+0.9% +$32.1K 0.53% 63
2020
Q4
$3.19M Sell
18,220
-722
-4% -$125K 0.48% 65
2020
Q3
$3.06M Buy
18,942
+202
+1% +$32K 0.55% 57
2020
Q2
$2.67M Sell
18,740
-1,543
-8% -$213K 0.5% 62
2020
Q1
$2.2M Sell
20,283
-1,245
-6% -$179K 0.46% 66
2019
Q4
$3.13M Sell
21,528
-1,094
-5% -$158K 0.51% 64
2019
Q3
$3.27M Sell
22,622
-926
-4% -$135K 0.56% 61
2019
Q2
$3.5M Sell
23,548
-1,117
-5% -$156K 0.62% 57
2019
Q1
$3.24M Buy
24,665
+1,175
+5% +$145K 0.6% 63
2018
Q4
$2.55M Sell
23,490
-29
-0.1% -$3.88K 0.59% 58
2018
Q3
$3.51M Buy
23,519
+478
+2% +$72.7K 0.71% 53
2018
Q2
$3.55M Buy
23,041
+605
+3% +$91.3K 0.77% 53
2018
Q1
$3.12M Sell
22,436
-64
-0.3% -$9.4K 0.72% 59
2017
Q4
$3.08M Sell
22,500
-41
-0.2% -$5.42K 0.71% 57
2017
Q3
$2.92M Sell
22,541
-570
-2% -$76K 0.72% 53
2017
Q2
$3.06M Buy
23,111
+116
+0.5% +$14.2K 0.8% 52
2017
Q1
$2.83M Buy
22,995
+105
+0.5% +$12.4K 0.77% 53
2016
Q4
$2.52M Sell
22,890
-1,694
-7% -$188K 0.75% 53
2016
Q3
$2.9M Sell
24,584
-355
-1% -$41.8K 0.91% 44
2016
Q2
$2.79M Buy
24,939
+82
+0.3% +$8.82K 0.95% 40
2016
Q1
$2.5M Buy
24,857
+960
+4% +$92K 0.88% 41
2015
Q4
$2.54M Buy
23,897
+12,106
+103% +$1.25M 0.93% 39
2015
Q3
$1.1M Buy
11,791
+1,094
+10% +$113K 0.44% 71
2015
Q2
$1.11M Sell
10,697
-87
-0.8% -$9.06K 0.43% 74
2015
Q1
$1.17M Buy
10,784
+98
+0.9% +$10.1K 0.45% 76
2014
Q4
$991K Buy
10,686
+2,067
+24% +$183K 0.41% 79
2014
Q3
$753K Sell
8,619
-524
-6% -$47.3K 0.33% 83
2014
Q2
$804K Sell
9,143
-553
-6% -$47.9K 0.36% 84
2014
Q1
$818K Sell
9,696
-757
-7% -$60.4K 0.4% 82
2013
Q4
$821K Buy
+10,453
New +$892K 0.42% 80

Other funds holding LH

Stonebridge Capital Advisors's LH Position: Q1 2026 in Review

Stonebridge Capital Advisors reduced its Labcorp (LH) stake by 2.2% in Q1 2026, selling an estimated $27.1K and leaving 4,422 shares worth $1.18M. The position accounts for 0.08% of the portfolio, ranked #107.

Stonebridge Capital Advisors first reported a position in LH in Q4 2013 and has held it in 50 quarters since. The position peaked at $8.38M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Stonebridge Capital Advisors held 4,422 shares of Labcorp worth $1.18M as of Q1 2026.
  • Stonebridge Capital Advisors sold 100 Labcorp shares in Q1 2026, an estimated $27.1K.
  • Labcorp made up 0.08% of Stonebridge Capital Advisors's portfolio in Q1 2026, its #107 holding.
  • Stonebridge Capital Advisors first reported a position in Labcorp in Q4 2013 and has held it in 50 quarters since.
  • Stonebridge Capital Advisors's Labcorp position peaked at $8.38M in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Stonebridge Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.